John Trizzino
Presidente presso NOVAVAX, INC.
Patrimonio netto: 154 402 $ in data 30/04/2024
Profilo
John J. Trizzino è CFO, EVP, Chief Commercial & Business Officer di Novavax, Inc. Trizzino è stato precedentemente impiegato come amministratore delegato e direttore di ImmunoVaccine, Inc., vicepresidente del franchising dei vaccini di MedImmune LLC, vicepresidente dello sviluppo commerciale di ID Biomedical Corp. e vicepresidente dello sviluppo commerciale di Henry Schein, Inc. È stato anche membro del consiglio del Tech Council of Maryland, Inc. Si è laureato alla Long Island University e ha conseguito un MBA alla Leonard N Stern School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NOVAVAX, INC.
0.03% | 22/04/2024 | 39 089 ( 0.03% ) | 154 402 $ | 30/04/2024 |
Posizioni attive di John Trizzino
| Società | Posizione | Inizio |
|---|---|---|
| NOVAVAX, INC. | Presidente | 20/11/2023 |
Precedenti posizioni note di John Trizzino
| Società | Posizione | Fine |
|---|---|---|
| IMV INC. | Amministratore Delegato | 01/09/2013 |
| NOVAVAX, INC. | Corporate Officer/Principal | 06/09/2011 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01/01/2009 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/01/2009 |
| HENRY SCHEIN, INC. | Corporate Officer/Principal | 01/01/2004 |
Formazione di John Trizzino
| Long Island University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| HENRY SCHEIN, INC. | Distribution Services |
| NOVAVAX, INC. | Health Technology |
| IMV INC. | Health Technology |
| Aziende private | 3 |
|---|---|
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Tech Council of Maryland, Inc.
 Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
- Borsa valori
- Insiders
- John Trizzino